AMGN

Q: What is the price of Amgen (AMGN) today?

The price of Amgen (AMGN) today is US$ 290,13, with a variation of -6.6% compared to the last year. The price of Amgen (AMGN) started the year trading around US$ 260,64 and today it is at US$ 290,13. Follow the real-time price chart, the historical price of Amgen (AMGN), and stock data from Ibovespa and international markets.

Q: When does Amgen (AMGN) pay dividends?

Amgen (AMGN) distributed dividends in the last year,in the months of March, June and September totaling US$ 7,14. The Dividend Yield for the last 12 months is 3,15%.

Q: Amgen (AMGN) is it worth it?

Currently, Amgen (AMGN) is priced at US$ 290,13, with a P/E of 30,70%, representing a deviation of 23,16% from its historical average P/E. In the last year, the stock showed a variation of -6.6% in its price and distributed US$ 7,14 in dividends, resulting in a Dividend Yield of 3,15%. The total shareholder return was -6,60%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Amgen (AMGN)?

Investing in stocks of Amgen (AMGN) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Amgen (AMGN) yield today?

The yield of Amgen (AMGN) was 5,02% in the last month, -6,60% in the last year and 41,90% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 9,39 in dividends, um Dividend Yield de 3,15%.If you wanted to buy 100 stocks of Amgen (AMGN) today, the total investment would be US$ 29.013,00, based on the current price of US$ 290,13.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 27.098,14In 5 years: US$ 41.169,45In 10 years: 76.588,52It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Amgen Inc.

Price

US$ 290,13

variation (12m)

-6,60%

p/l

30,70

p/vp

21,58

DIVIDEND YIELD

3,15%

price AMGN

BVMF

AMGN

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of AMGN

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

5,02%

3 months

-0,94%

1 year

-6,60%

2 years

8,39%

5 years

41,90%

10 years

163,98%

real profitability

profitability minus inflation.

1 month

5,02%

3 months

-1,30%

1 year

-10,70%

2 years

-1,07%

5 years

4,86%

10 years

58,05%

Indicators AMGN

check out the fundamentals of Amgen shares

P/E

30,70

Sector: -3,47 Industry: -3,47

P/SALES RATIO (PSR)

4,50

Sector: -4,23 Industry: -4,23

P/BV

21,58

Sector: 1,89 Industry: 1,89

DIVIDEND YIELD (DY)

3,15%

Sector: - Industry: -

ROA

5,94%

Sector: -63,87% Industry: -63,87%

ROE

70,29%

Sector: -70,87% Industry: -70,87%

ROIC

15,00%

Sector: -2.084,36% Industry: -2.084,36%

NET MARGIN

14,67%

Sector: -41,75% Industry: -41,75%

GROSS MARGIN

66,00%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

24,73%

Sector: -41,04% Industry: -41,04%

P/EBITDA

18,32

Sector: -3,65 Industry: -3,65

P/EBIT

18,32

Sector: -3,64 Industry: -3,64

P/ASSET

1,82

Sector: 1,41 Industry: 1,41

BVPS

13,81

Sector: 1,84 Industry: 1,84

EPS

9,70

Sector: -2,20 Industry: -2,20

EQUITY / ASSETS

0,08

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

6,74%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-6,89%

Sector: - Industry: -

FAIR PRICE OF Amgen ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 290,13

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-81,08%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

AMGN indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,80	5,78	32,50%	2,69%	US$ 453,87 B	27,75%
PFE	16,92	1,75	10,33%	6,25%	US$ 155,60 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	16,20	10,21	62,99%	2,83%	US$ 265,17 B	34,74%
MRK	12,67	4,56	36,03%	3,59%	US$ 223,87 B	28,16%
AZN	28,39	5,90	20,79%	1,83%	US$ 264,46 B	16,23%
BMY	17,97	5,29	29,44%	5,41%	US$ 92,49 B	10,71%
GILD	19,99	7,16	35,82%	2,79%	US$ 140,30 B	24,71%
ZTS	24,61	13,09	53,20%	1,32%	US$ 65,16 B	28,00%
HALO	14,26	25,08	175,93%	0,00%	US$ 8,35 B	48,21%
REGN	13,97	2,10	15,06%	0,44%	US$ 63,00 B	31,83%
VRTX	28,59	6,03	21,11%	0,00%	US$ 103,65 B	31,22%
MCK	24,89	-106,90	-429,55%	0,40%	US$ 92,26 B	0,97%
CAH	26,56	-13,96	-52,54%	1,31%	US$ 36,76 B	0,60%
ADMA	17,05	8,87	52,03%	0,00%	US$ 3,53 B	43,51%
BIIB	13,23	1,33	10,08%	0,00%	US$ 23,50 B	17,46%
HRMY	8,91	2,01	22,58%	0,00%	US$ 1,55 B	22,19%

comparison of AMGN with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History AMGN

current DY: 3,15%

5-year average DY: 3,34%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	22/08/2025	12/09/2025	2,38000000
Dividends	16/05/2025	06/06/2025	2,38000000
Dividends	14/02/2025	07/03/2025	2,38000000
Dividends	18/11/2024	09/12/2024	2,25000000
Dividends	16/08/2024	06/09/2024	2,25000000
Dividends	17/05/2024	07/06/2024	2,25000000
Dividends	16/02/2024	07/03/2024	2,25000000
Dividends	17/11/2023	08/12/2023	2,13000000
Dividends	18/08/2023	08/09/2023	2,13000000
Dividends	18/05/2023	08/06/2023	2,13000000
Dividends	15/02/2023	08/03/2023	2,13000000
Dividends	17/11/2022	08/12/2022	1,94000000
Dividends	18/08/2022	08/09/2022	1,94000000
Dividends	17/05/2022	08/06/2022	1,94000000
Dividends	15/02/2022	08/03/2022	1,94000000
Dividends	16/11/2021	08/12/2021	1,76000000
Dividends	17/08/2021	08/09/2021	1,76000000
Dividends	17/05/2021	08/06/2021	1,76000000
Dividends	15/02/2021	08/03/2021	1,76000000
Dividends	16/11/2020	08/12/2020	1,60000000
Dividends	17/08/2020	08/09/2020	1,60000000
Dividends	18/05/2020	08/06/2020	1,60000000
Dividends	14/02/2020	06/03/2020	1,60000000
Dividends	15/11/2019	06/12/2019	1,45000000
Dividends	15/08/2019	06/09/2019	1,45000000
Dividends	17/05/2019	07/06/2019	1,45000000
Dividends	15/02/2019	08/03/2019	1,45000000
Dividends	16/11/2018	07/12/2018	1,32000000
Dividends	17/08/2018	07/09/2018	1,32000000
Dividends	17/05/2018	08/06/2018	1,32000000
Dividends	15/02/2018	08/03/2018	1,32000000
Dividends	17/11/2017	08/12/2017	1,15000000
Dividends	17/08/2017	08/09/2017	1,15000000
Dividends	17/05/2017	08/06/2017	1,15000000
Dividends	15/02/2017	08/03/2017	1,15000000
Dividends	16/11/2016	08/12/2016	1,00000000
Dividends	17/08/2016	08/09/2016	1,00000000
Dividends	17/05/2016	08/06/2016	1,00000000
Dividends	16/02/2016	08/03/2016	1,00000000
Dividends	16/11/2015	07/12/2015	0,79000000
Dividends	17/08/2015	08/09/2015	0,79000000
Dividends	14/05/2015	05/06/2015	0,79000000
Dividends	12/02/2015	06/03/2015	0,79000000
Dividends	13/11/2014	05/12/2014	0,61000000
Dividends	14/08/2014	05/09/2014	0,61000000
Dividends	15/05/2014	06/06/2014	0,61000000
Dividends	13/02/2014	07/03/2014	0,61000000
Dividends	14/11/2013	06/12/2013	0,47000000
Dividends	16/08/2013	06/09/2013	0,47000000
Dividends	16/05/2013	07/06/2013	0,47000000
Dividends	13/02/2013	07/03/2013	0,47000000
Dividends	15/11/2012	07/12/2012	0,36000000
Dividends	16/08/2012	07/09/2012	0,36000000
Dividends	16/05/2012	07/06/2012	0,36000000
Dividends	15/02/2012	07/03/2012	0,36000000
Dividends	17/11/2011	08/12/2011	0,28000000
Dividends	18/08/2011	08/09/2011	0,28000000

ABOUT THE COMPANY Amgen

Amgen Inc.

Average user rating I10

4.0 (35 people)

Estados Unidos

45 years

Foundation: 1980

1983

Year of debut on the stock exchange - 42 years

19.200

Employees

The Company Amgen Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 160,26 Billions, having a net worth of $ 7,43 Billions.

With a total of 19.200 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 35,59 Billions, which generated a profit in the amount of $ 5,22 Billions.

As for its main indicators, the Company has a P/E ratio of 30,70, a P/BV ratio of 21,58 and in the last 12 months the dividend yield of AMGN was at 3,15%.

The Company is traded internationally through the ticker AMGN.

Market value

US$ 160,26 Billions

Net worth

US$ 7,43 Billions

US$ 7.428.000.000,00

Assets

US$ 87,90 Billions

US$ 87.897.000.000,00

Total Number of Shares

538,00 Milhões

538.000.000

Average Daily Trading Volume

US$ 2,35 Milhões

US$ 2.352.998,30

Sector

Health Care

Industry

Biotechnology

AMGN

AMGN revenue and profits

AMGN results

DRAG THE FRAME TO SEE MORE DATA

AMGN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12 M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12 M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12 M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12 M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12 M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12 M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12 M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

Frequently Asked Questions

What is the price of Amgen (AMGN) today?

The price of Amgen (AMGN) today is US$ 290,13, with a variation of -6.6% compared to the last year. The price of Amgen (AMGN) started the year trading around US$ 260,64 and today it is at US$ 290,13. Follow the real-time price chart, the historical price of Amgen (AMGN), and stock data from Ibovespa and international markets.

When does Amgen (AMGN) pay dividends?

Amgen (AMGN) distributed dividends in the last year,in the months of March, June and September totaling US$ 7,14. The Dividend Yield for the last 12 months is 3,15%.

Amgen (AMGN) is it worth it?

Currently, Amgen (AMGN) is priced at US$ 290,13, with a P/E of 30,70%, representing a deviation of 23,16% from its historical average P/E. In the last year, the stock showed a variation of -6.6% in its price and distributed US$ 7,14 in dividends, resulting in a Dividend Yield of 3,15%. The total shareholder return was -6,60%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Amgen (AMGN)?

Investing in stocks of Amgen (AMGN) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Amgen (AMGN) yield today?

The yield of Amgen (AMGN) was 5,02% in the last month, -6,60% in the last year and 41,90% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 9,39 in dividends, um Dividend Yield de 3,15%.

If you wanted to buy 100 stocks of Amgen (AMGN) today, the total investment would be US$ 29.013,00, based on the current price of US$ 290,13.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 27.098,14
In 5 years: US$ 41.169,45
In 10 years: 76.588,52

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

AMGN

Amgen Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of AMGN

check out the fundamentals of Amgen shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 3,15%

5-year average DY: 3,34%

type

date with

payment date

value

ABOUT THE COMPANY Amgen

Amgen Inc.

Estados Unidos

45 years

1983

19.200

PROFIT X PRICE AMGN

AMGN results

AMGN cash flow

evolution of assets - AMGN

AMGN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions